FGF23 and chronic kidney disease: Chronic kidney disease reduces DMP1 expression in osteocytes, while DMP1 supplementation prevents osteocyte apoptosis, lowers FGF23 expression, increases serum phosphate, and prevents the development of left ventricular hypertrophy in a chronic kidney disease mice model (35, 76).